先看重点
在韩国75名受试者中,11款消费级睡眠追踪设备与实验室多导睡眠图相比,睡眠分期一致性差异很大:宏平均F1分数最高为0.69,最低为0.26。受试者来自医院和睡眠门诊,结果未必等同于日常居家使用。
证据类型
测量验证研究/综述
解读依据
公开摘要
阅读重点
参照与测量误差
研究在问什么
很多人使用睡眠追踪设备,但很少有研究在同一大样本中把多款热门设备与临床标准相比。作者检验了可穿戴设备、床边设备(nearable)和手机应用(airable)与多导睡眠图(夜间睡眠实验室记录)的一致程度。
研究了谁,如何研究
前瞻性多中心验证研究,评估11款商用设备:5款可穿戴设备(Google Pixel Watch、Galaxy Watch 5、Fitbit Sense 2、Apple Watch 8、Oura Ring 3)、3款床边设备(Withings Sleep Tracking Mat、Google Nest Hub 2、Amazon Halo Rise)和3款手机应用(SleepRoutine、SleepScore、Pillow)。为避免设备相互干扰,分为2组,每组(8款设备)分别与多导睡眠图对照。75名参与者来自韩国一家三级医院和一家基层睡眠专科诊所,以宏平均F1分数评价逐时段的睡眠分期一致性。
主要发现
以下为作者报告的结果。数字须连同人群和不确定性一起阅读。
- 1共分析11款设备的349,114个时段,收集到3890小时设备睡眠记录和543小时多导睡眠图记录。逐时段睡眠分期一致性差异很大,宏平均F1分数从0.26(最低)到0.69(最高)。
- 2分期表现上,SleepRoutine在清醒和快速眼动(REM)睡眠上表现最好,而Google Pixel Watch、Fitbit Sense 2等可穿戴设备在深睡眠上表现更优。
- 3误差与设备类型有关:可穿戴设备在睡眠效率上存在较高的比例偏倚,床边设备则在入睡潜伏期上存在较高的比例偏倚。
- 4宏平均F1分数随BMI、睡眠效率和呼吸暂停低通气指数而变化,男女之间差异很小。
局限与不确定性
- 1测试在医院和睡眠门诊进行,仅有75名参与者,日常居家睡眠的追踪情况可能不同。
- 2摘要没有说明哪款设备得到0.69或0.26,除分期亮点外也未给出各设备的具体数值。
- 3每组设备仅作为8款设备的整体与多导睡眠图比较,不同组的设备并非在同一夜佩戴。
- 4本解读仅基于摘要。
对日常健康的启示
不要默认所有设备识别睡眠分期的能力相同;与睡眠实验室的一致性差距很大。部分设备与多导睡眠图一致性较高,但分期准确性仍因设备和个人睡眠情况而异。建议把分期数据当作粗略估计。
如何联系自己的数据
无论使用Oura Ring、Apple Watch、Fitbit还是床边设备,都建议用同一设备观察自己数周的夜间总量变化,而不要只看单夜的分期分钟数。深睡眠、清醒时间和入睡潜伏期的估计因设备而异,不同品牌的数值不宜直接比较。
如何理解这类证据
一致性取决于设备、固件、参照、人群和场景。相关性不等于一致性;验证某个指标不等于已证明诊断或治疗获益。
作者的结构化摘要 English
以下英文摘要按记录的开放许可转载,属于作者原始材料,不是 MoveVitals 的解读。上方已提供研究解读,分别说明作者结果与本站解释;重要结论可直接核对原文。
Background
Consumer sleep trackers (CSTs) have gained significant popularity because they enable individuals to conveniently monitor and analyze their sleep. However, limited studies have comprehensively validated the performance of widely used CSTs. Our study therefore investigated popular CSTs based on various biosignals and algorithms by assessing the agreement with polysomnography.
Objective
This study aimed to validate the accuracy of various types of CSTs through a comparison with in-lab polysomnography. Additionally, by including widely used CSTs and conducting a multicenter study with a large sample size, this study seeks to provide comprehensive insights into the performance and applicability of these CSTs for sleep monitoring in a hospital environment.
Methods
The study analyzed 11 commercially available CSTs, including 5 wearables (Google Pixel Watch, Galaxy Watch 5, Fitbit Sense 2, Apple Watch 8, and Oura Ring 3), 3 nearables (Withings Sleep Tracking Mat, Google Nest Hub 2, and Amazon Halo Rise), and 3 airables (SleepRoutine, SleepScore, and Pillow). The 11 CSTs were divided into 2 groups, ensuring maximum inclusion while avoiding interference between the CSTs within each group. Each group (comprising 8 CSTs) was also compared via polysomnography.
Results
The study enrolled 75 participants from a tertiary hospital and a primary sleep-specialized clinic in Korea. Across the 2 centers, we collected a total of 3890 hours of sleep sessions based on 11 CSTs, along with 543 hours of polysomnography recordings. Each CST sleep recording covered an average of 353 hours. We analyzed a total of 349,114 epochs from the 11 CSTs compared with polysomnography, where epoch-by-epoch agreement in sleep stage classification showed substantial performance variation. More specifically, the highest macro F1 score was 0.69, while the lowest macro F1 score was 0.26. Various sleep trackers exhibited diverse performances across sleep stages, with SleepRoutine excelling in the wake and rapid eye movement stages, and wearables like Google Pixel Watch and Fitbit Sense 2 showing superiority in the deep stage. There was a distinct trend in sleep measure estimation according to the type of device. Wearables showed high proportional bias in sleep efficiency, while nearables exhibited high proportional bias in sleep latency. Subgroup analyses of sleep trackers revealed variations in macro F1 scores based on factors, such as BMI, sleep efficiency, and apnea-hypopnea index, while the differences between male and female subgroups were minimal.
Conclusions
Our study showed that among the 11 CSTs examined, specific CSTs showed substantial agreement with polysomnography, indicating their potential application in sleep monitoring, while other CSTs were partially consistent with polysomnography. This study offers insights into the strengths of CSTs within the 3 different classes for individuals interested in wellness who wish to understand and proactively manage their own sleep.
来源与署名
Accuracy of 11 Wearable, Nearable, and Airable Consumer Sleep Trackers: Prospective Multicenter Validation Study.
Lee T, Cho Y, Cha KS, Jung J, Cho J, Kim H, Kim D, Hong J, Lee D, Keum M, Kushida CA, Yoon IY, Kim JW.
JMIR mHealth and uHealth · 2023-11-02
DOI: 10.2196/50983 ↗PubMed · 37917155 ↗Europe PMC · 记录的开放许可: cc by ↗摘要版权归原作者,依据来源记录的开放许可转载。中文译文辅助阅读,英文摘要用于核对术语与具体数值;本站的方法学解释与作者结论分别呈现。
MoveVitals 编辑解读 · 健康教育内容 · 未记录个人临床审阅
来源核验日期 2026-11-01
实用健康指南
放在一起读
运动改善45岁及以上睡眠障碍者的睡眠质量评分
汇总23项随机对照试验、共1,478名45至77岁睡眠障碍成年人的数据,运动改善了匹兹堡睡眠质量指数评分(SMD 0.62,95%置信区间0.40–0.83),网络分析中有氧运动效果最大(SMD 1.34,95%可信区间0.86–1.82)。证据确定性为低到中等,结局是问卷评分,每周约539 MET-min的最佳剂量是模型估计值,不是处方。
Journal of Exercise Science & Fitness
睡眠规律性比睡眠时长更能预测英国成年人的死亡风险
在60,977名佩戴腕式加速度计一周的英国生物样本库成年人中,睡眠最规律的五分之一人群,经完全校正后的全因死亡风险比为0.70(95%置信区间0.59–0.83),对照为最不规律的五分之一,随访约6.3年,共1859人死亡。规律性对数据的拟合优于睡眠时长,但这是只依据一周数据的观察性研究。
Sleep
延长睡眠使超重成年人每日能量摄入减少约270千卡
在80名平时睡眠不足6.5小时的超重成年人中,两周的延长睡眠指导使睡眠增加约1.2小时,实测能量摄入比对照组少270.4千卡/天(95%置信区间−393.4至−147.4)。这是一项为期短、单中心、人群较窄的试验,不能说明体重会持续下降,也不能说明对睡眠本就充足的人有益。
JAMA Internal Medicine
50岁和60岁时每晚睡6小时及以下,与日后痴呆风险较高相关
在7959名英国公务员中随访约25年,50岁时每晚睡6小时及以下者的痴呆风险比为1.22(95%置信区间1.01–1.48),60岁时为1.37(1.10–1.72),均高于睡7小时者;长期持续睡眠偏短者为1.30(1.00–1.69)。睡眠主要靠自报,且为观察性研究,早期脑部病变等因素可能解释了部分关联。
Nature Communications

